Continued Assessment of the Fasting Mimicking Diet as an Adjuvant Cancer Therapy
In conclusion, FMD cycles have high potential to be effective in increasing the toxicity of a range of therapies against ALL and other blood cancers and should be tested in randomized clinical trials, especially in combination with immunotherapy and low toxicity cancer therapies.
In summary, we present a new strategy for improving leukemia treatment by combining FMD with chemotherapy to promote the killing of ALL cells in part by an immune-dependent mechanism. Fasting/FMD has been shown to reduce chemotherapy-associated toxicity in pre-clinical and clinical studies and thus represents a safe and potentially effective treatment adjunct for leukemia patients which should be tested clinically.
Source: Fight Aging! - Category: Research Authors: Reason Tags: Medicine, Biotech, Research Source Type: blogs
More News: Acute Leukemia | Acute Lymphoblastic Leukemia | Acute Myeloid Leukemia | Biotechnology | Breast Cancer | Cancer | Cancer & Oncology | Cancer Therapy | Chemotherapy | Clinical Trials | Diets | HER2 | Immunotherapy | Insulin | Leukemia | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Nutrition | Ovarian Cancer | Ovaries | Research | Sports Medicine | Study | Toxicology